Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New gel shows promise for stubborn warts in extended trial

NCT ID NCT07457918

First seen Mar 21, 2026 · Last updated May 19, 2026 · Updated 16 times

Summary

This study follows people who previously took part in a wart treatment study (COVE-2 or COVE-3) to see if YCANTH gel is safe and works over a longer period. Participants with remaining warts can get up to 4 more treatments, applied every 21 days. The goal is to clear all warts, and those who become wart-free will be monitored for up to a year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS (HPV) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Florida Center for Dermatology, P.A.

    RECRUITING

    Saint Augustine, Florida, 32080, United States

  • Optima Research Boardman

    RECRUITING

    Boardman, Ohio, 44512, United States

  • Texas Dermatology

    RECRUITING

    San Antonio, Texas, 78235, United States

  • The Indiana Clinical Trials Center, PC

    RECRUITING

    Plainfield, Indiana, 46168, United States

Conditions

Explore the condition pages connected to this study.